Results 121 to 130 of about 2,992 (185)

Stimulating amyloid-β clearance in cerebral amyloid angiopathy with low-sodium oxybate and/or non-invasive vagus nerve stimulation (Clear-Brain): study protocol for a randomised pre-post trial. [PDF]

BMJ Open
Schriemer SE, Hirschler L, van Etten ES, van Zwet EW, Lammers GJ, Liebler EJ, van Walderveen MAA, Slats AM, van Es ACGM, Verbeek MM, van Osch MJP, Wermer MJH, Fronczek R.   +12 more
europepmc   +1 more source

Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia. [PDF]

J Clin Sleep Med, 2023
Morse AM, Dauvilliers Y, Arnulf I, Thorpy MJ, Foldvary-Schaefer N, Chandler P, Chen A, Hickey L, Black J, Bogan RK.   +9 more
europepmc   +1 more source

Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy. [PDF]

CNS Drugs, 2023
Bogan RK, Foldvary-Schaefer N, Skowronski R, Chen A, Thorpy MJ.   +4 more
europepmc   +1 more source

Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons [PDF]

, 2009
A Guidotti, A. K. Goodwin, AK Goodwin, AK Goodwin, AK Goodwin, C Arena, C. Jakobs, CJ Teter, CM Fiebre de, D Thai, E. E. W. Jansen, E. M. Weerts, EM Weerts, EM Weerts, GP Galloway, H Ladinsky, HOM Cook, J Mordenti, JA Davies, JC Winter, JF Navarro, JP Winickoff, JS Shumate, JT Lettieri, JT Lettieri, K Miotto, K. M. Gibson, KM Gibson, LE Baker, LP Carter, LP Carter, LR McMahon, M Ingels, M Shannon, MB Scharf, NA Ator, NJ Giarman, OC Snead, OC Snead, OC Snead, OC Snead 3rd, P Palatini, P. R. Brown, PB Dews, R Maxwell, RB Palmer, RD Irwin, RH Roth, RH Roth, RJ Sevak, S Abanades, SA Barker, SE Lukas, TB Vree, Y Itzhak   +54 more
core   +2 more sources

Sodium Oxybate for Alcohol Dependence: A Network Meta-Regression Analysis Considering Population Severity at Baseline and Treatment Duration. [PDF]

Alcohol Alcohol, 2023
Guiraud J, Addolorato G, Aubin HJ, Bachelot S, Batel P, de Bejczy A, Benyamina A, Caputo F, Couderc M, Dematteis M, Goudriaan AE, Gual A, Lecoustey S, Lesch OM, Maremmani I, Nutt DJ, Paille F, Perney P, Rehm J, Rolland B, Scherrer B, Simon N, Söderpalm B, Somaini L, Sommer WH, Spanagel R, Walter H, van den Brink W.   +27 more
europepmc   +1 more source

Long-term safety and maintenance of efficacy of sodium oxybate in the treatment of narcolepsy with cataplexy in pediatric patients. [PDF]

J Clin Sleep Med, 2022
Lecendreux M, Plazzi G, Dauvilliers Y, Rosen CL, Ruoff C, Black J, Parvataneni R, Guinta D, Wang YG, Mignot E.   +9 more
europepmc   +1 more source

Behavioral Sleep Medicine Services for Hypersomnia Disorders: A Survey Study [PDF]

, 2016
Megan Crawford
core   +1 more source

Correction to: Changes in Cataplexy Frequency in a Clinical Trial of Lower‑Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications. [PDF]

CNS Drugs, 2022
Dauvilliers Y, Šonka K, Bogan RK, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Chen A, Black J, Skobieranda F, Thorpy MJ.   +10 more
europepmc   +1 more source

Sleep-related painful erections treated with sodium oxybate. [PDF]

J Clin Sleep Med
Chaudhary HS, Zeidman E, Punjani N, Tashman Y.   +3 more
europepmc   +1 more source

Correction to: Sodium oxybate in treatment-resistant rapid-eye-movement sleep behavior disorder. [PDF]

Sleep, 2023
europepmc   +1 more source